9. Maeder M T, Strobel W, Christ M, et al. Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem, 2015, 48(4-5): 340-346.
[2]
10. Shen P, Han Y, Cai B, et al. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome. Sleep Breath, 2015, 19(2): 515-522.
[3]
11. Iturriaga R, Moya E A, Del Rio R. Inflammation and oxidative stress during intermittent hypoxia: The impact on chemoreception. Exp Physiol, 2015, 100(2): 149-155.
[4]
12. Passali D, Corallo G, Yaremchuk S, et al. Oxidative stress in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital, 2015, 35(6): 420-425.
[5]
13. Ntalapascha M, Makris D, Kyparos A, et al. Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath, 2013, 17(2): 549-555.
15. Berghaus T M, Witkowska A, Wagner T, et al. Obstructive sleep apnea might trigger acute pulmonary embolism: Results from a cohort study. Clin Res Cardiol, 2016, 105(11): 938-943.
[8]
16. Alonso-Fernandez A, Garcia Suquia A, de la Pena M, et al. Obstructive sleep apnea is a risk factor for recurrent venous thromboembolism. Chest, 2016, 150(6): 1291-1301.
[9]
17. Alkhiary W, Morsy N E, Yousef A M, et al. Adenosine diphosphate-induced platelets aggregability in polysomnographically verified obstructive sleep apnea. Clin Appl Thromb Hemost, 2015, 22(15): 118-225.
[10]
18. Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol, 2016, 99(5): 272-285.
[11]
19. Borvik T, Braekkan S K, Enga K, et al. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J, 2016, 47(2): 473-481.
[12]
20. Chen W J, Lin C C, Lin C Y, et al. Pulmonary embolism in chronic obstructive pulmonary disease: A population-based cohort study. Copd, 2014, 11(4): 438-443.
22. Keenan C R, White R H. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med, 2007, 13(5): 377-383.
[15]
23. Karamanli H, Ozol D, Ugur K S, et al. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath, 2014, 18(2): 251-256.
[16]
24. Wang Y, Su M, Zhang X. Effects of continuous positive airway pressure treatment of inflammatory factors in patients with overlap syndrome. Zhonghua Yi Xue Za Zhi, 2014, 94(6): 416-419.
[17]
1. Peng Y H, Liao W C, Chung W S, et al. Association between obstructive sleep apnea and deep vein thrombosis/pulmonary embolism: A population-based retrospective cohort study. Thromb Res, 2014, 134(2): 340-345.
[18]
2. Alonso-Fernandez A, de la Pena M, Romero D, et al. Association between obstructive sleep apnea and pulmonary embolism. Mayo Clin Proc, 2013, 88(6): 579-587.
[19]
3. Lippi G, Mattiuzzi C, Franchini M. Sleep apnea and venous thromboembolism. A systematic review. Thromb Haemost, 2015, 114(5): 958-963.
7. McNicholas W T. Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis, 2009, 51(5): 392-399.
[24]
8. Svensson M, Venge P, Janson C, et al. Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res, 2012, 21(2): 147-154.
